RESEARCH ARTICLE
https://onlinelibrary.wiley.com/doi/full/10.1002/jcla.22576
Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer‐associated malignant pleural effusionFan Zhang Junjun Wang Xiaoyong Zheng Lijuan Hu Jie Chen
First published: 23 May 2018
https://doi.org/10.1002/jcla.22576[/BCOLOR]
Abstract
Background
Midkine (MK) level has been shown to be elevated in serum of patients with nonsmall cell lung cancer (NSCLC). However, the diagnostic value of MK in pleural effusion in NSCLC has not been well validated and established. detection of pMK + pCA125 + pADA suggested that the sensitivity, specificity, and AUC was 82.54%, 74.19% at the cutoff 0.47 and diagnostic performance was higher than others.
ConclusionJoint detection of pMK + pCA125 + pADA can be used as a good indicator for the identification of MPE of NSCLC.
- Forums
- ASX - By Stock
- AN1
- Study Presentation: Midkine and NSCLC (Biomarker)
Study Presentation: Midkine and NSCLC (Biomarker), page-2
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $350 | 50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 775527 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 5022 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 775527 | 0.006 |
1 | 300000 | 0.005 |
3 | 825000 | 0.004 |
1 | 600000 | 0.003 |
2 | 500000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 5022 | 1 |
0.009 | 280000 | 1 |
0.010 | 157763 | 1 |
0.013 | 750000 | 1 |
0.015 | 340000 | 2 |
Last trade - 11.14am 09/08/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |